Skip to main content

Northern Trust Corp

SEC CIK
0000073124
Latest filing
Aug 13, 2026

CATX holding history

Perspective Therapeutics, Inc. in every 13F filed by Northern Trust Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CATX overviewAll 13F holders of CATXFull Q2 2026 holdings

Shares (Q2 2026)
791,774
Value
$2.70M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CATX by Northern Trust Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026791,774$2.70M<0.1%+262,846+49.7%AddedHolders
Q1 2026528,928$2.21M<0.1%+89,714+20.4%AddedHolders
Q4 2025439,214$1.21M<0.1%−31,746−6.7%ReducedHolders
Q3 2025470,960$1.62M<0.1%−8,249−1.7%ReducedHolders
Q2 2025479,209$1.65M<0.1%+8,325+1.8%AddedHolders
Q1 2025470,884$1.00M<0.1%−16,389−3.4%ReducedHolders
Q4 2024487,273$1.55M<0.1%+13,115+2.8%AddedHolders
Q3 2024474,158$6.33M<0.1%+336,318+244.0%AddedHolders
Q2 2024137,840$1.37M<0.1%−707,464−83.7%ReducedHolders
Q1 2024845,304$1.01M<0.1%+451,992+114.9%AddedHolders
Q4 2023393,312$158.1K<0.1%00.0%UnchangedHolders
Q3 2023393,312$107.6K<0.1%−1,682−0.4%ReducedHolders
Q2 2023394,994$263.9K<0.1%00.0%UnchangedHolders
Q1 2023394,994$252.0K<0.1%+150,634+61.6%AddedHolders
Q4 2022244,360$60.4K<0.1%00.0%UnchangedHolders
Q3 2022244,360$56.0K<0.1%00.0%UnchangedHolders
Q2 2022244,360$76.0K<0.1%−17,189−6.6%ReducedHolders
Q1 2022261,549$95.0K<0.1%00.0%UnchangedHolders
Q4 2021261,549$101.0K<0.1%00.0%UnchangedHolders
Q3 2021261,549$165.0K<0.1%−8,338−3.1%ReducedHolders
Q2 2021269,887$215.0K<0.1%−13,483−4.8%ReducedHolders
Q1 2021283,370$309.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.